Skip to main content
Erschienen in: International Journal of Colorectal Disease 6/2018

12.03.2018 | Original Article

Improved perioperative care is associated with improved long-term survival in colorectal cancer

verfasst von: Eligijus Poskus, Marius Kryzauskas, Tomas Poskus, Saulius Mikalauskas, Narimantas Evaldas Samalavicius, Oleg Aliosin, Sarunas Dailidenas, Algimantas Tamelis, Zilvinas Saladzinskas, Paulius Lizdenis, Audrone Jakaitiene, Giedre Smailyte, Kestutis Strupas

Erschienen in: International Journal of Colorectal Disease | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare perioperative colorectal cancer care and survival in patient cohorts operated in 2005 and in 2010 in Lithuania.

Methods

Comparative observational cohort study was performed. The study was conducted in the three Lithuanian cancer hospitals. Patients, who underwent curative surgery for colorectal cancer in 2005 and 2010, were included. Demographic characteristics, distribution of the tumors, preoperative diagnostics and staging, surgical treatment, the quality of pathological examination, morbidity, and mortality were analyzed. One- and 5-year overall survival data were compared between the groups.

Results

Colorectal cancer diagnostics and treatment improved from 2005 to 2010 significantly. The disease was identified as stage III–IV for 45 vs. 48% of the patients; however, computed tomography staging scan was performed only for 5.9 vs. 17.8% in 2005 and 2010, respectively. Laparoscopic operations were performed 1.5 vs. 10.5% and abdominoperineal resections—42.7 vs. 31.7% in 2005 and 2010, respectively. The number of harvested lymph nodes was mentioned in 55.8 vs. 97.7% of the cases, whereas more than 12 lymph nodes were examined in 18 vs. 66.6% of cases after histological examination. The overall 5-year survival was 52.1 vs. 63.1% (p < 0.0001), while the 5-year survival of the patients with stage IV of disease was 4.2 vs. 17.8% in 2005 and 2010, respectively.

Conclusion

Preoperative investigation, surgical treatment, pathological examination, and postoperative course are associated with improved overall survival in colorectal cancer patients, undergoing curative surgery in the resource-limited settings.
Literatur
1.
Zurück zum Zitat Lunevicius R, Poskus T, Samalavicius NE (2015) National burden of colorectal cancer in Lithuania and country’s ranking across 45 European nations. Oncol Lett 10(1):433–438CrossRefPubMedPubMedCentral Lunevicius R, Poskus T, Samalavicius NE (2015) National burden of colorectal cancer in Lithuania and country’s ranking across 45 European nations. Oncol Lett 10(1):433–438CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat De Angelis R, Sant M, Coleman MP et al (2014) Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study. Lancet Oncol 15(1):23–34CrossRefPubMed De Angelis R, Sant M, Coleman MP et al (2014) Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study. Lancet Oncol 15(1):23–34CrossRefPubMed
3.
Zurück zum Zitat Poškus E, Mikalauskas S, Jotautas V, Žeromskas P, Poškus T, Strupas K, Samalavičius NE, Lasinskas M, Sklepavičius A, Tamelis A, Saladžinskas Ž, Pavalkis D, Jakaitienė A, Smailytė G (2013) The pattern of colorectal cancer surgery in Lithuania in 2005: do results meet expectations? Medicina 49(3):124–131PubMed Poškus E, Mikalauskas S, Jotautas V, Žeromskas P, Poškus T, Strupas K, Samalavičius NE, Lasinskas M, Sklepavičius A, Tamelis A, Saladžinskas Ž, Pavalkis D, Jakaitienė A, Smailytė G (2013) The pattern of colorectal cancer surgery in Lithuania in 2005: do results meet expectations? Medicina 49(3):124–131PubMed
4.
Zurück zum Zitat Poskus T, Strupas K, Mikalauskas S, Bitinaitė D, Kavaliauskas A, Samalavicius NE, Saladzinskas Z (2015) Initial results of the National Colorectal Cancer Screening Program in Lithuania. Eur J Cancer Prev 24(2):76–80CrossRefPubMed Poskus T, Strupas K, Mikalauskas S, Bitinaitė D, Kavaliauskas A, Samalavicius NE, Saladzinskas Z (2015) Initial results of the National Colorectal Cancer Screening Program in Lithuania. Eur J Cancer Prev 24(2):76–80CrossRefPubMed
5.
Zurück zum Zitat Påhlman L, Laurberg S, Søreide O (2001) Structuring rectal cancer treatment in Scandinavia. Surg Oncol Clin N Am 10(4):855–862PubMed Påhlman L, Laurberg S, Søreide O (2001) Structuring rectal cancer treatment in Scandinavia. Surg Oncol Clin N Am 10(4):855–862PubMed
6.
Zurück zum Zitat Bülow S, Harling H, Iversen LH, Ladelund S, Danish Colorectal Cancer Group (2010) Improved survival after rectal cancer in Denmark. Color Dis 12(7 Online):e37–e42 Bülow S, Harling H, Iversen LH, Ladelund S, Danish Colorectal Cancer Group (2010) Improved survival after rectal cancer in Denmark. Color Dis 12(7 Online):e37–e42
7.
Zurück zum Zitat Van Leersum NJ, Snijders HS, Henneman D et al (2013) The Dutch surgical colorectal audit. Eur J Surg Oncol 39(10):1063–1070CrossRefPubMed Van Leersum NJ, Snijders HS, Henneman D et al (2013) The Dutch surgical colorectal audit. Eur J Surg Oncol 39(10):1063–1070CrossRefPubMed
8.
Zurück zum Zitat Breugom AJ, Boelens PG, van den Broek CB et al (2014) Quality assurance in the treatment of colorectal cancer: the EURECCA initiative. Ann Oncol 25(8):1485–1492CrossRefPubMed Breugom AJ, Boelens PG, van den Broek CB et al (2014) Quality assurance in the treatment of colorectal cancer: the EURECCA initiative. Ann Oncol 25(8):1485–1492CrossRefPubMed
9.
Zurück zum Zitat Guren MG, Kørner H, Pfeffer F, Myklebust TÅ, Eriksen MT, Edna TH, Larsen SG, Knudsen KO, Nesbakken A, Wasmuth HH, Vonen B, Hofsli E, Færden AE, Brændengen M, Dahl O, Steigen SE, Johansen MJ, Lindsetmo RO, Drolsum A, Tollåli G, Dørum LM, Møller B, Wibe A (2015) Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993–2010. Acta Oncol 54(10):1714–1722CrossRefPubMed Guren MG, Kørner H, Pfeffer F, Myklebust TÅ, Eriksen MT, Edna TH, Larsen SG, Knudsen KO, Nesbakken A, Wasmuth HH, Vonen B, Hofsli E, Færden AE, Brændengen M, Dahl O, Steigen SE, Johansen MJ, Lindsetmo RO, Drolsum A, Tollåli G, Dørum LM, Møller B, Wibe A (2015) Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993–2010. Acta Oncol 54(10):1714–1722CrossRefPubMed
11.
Zurück zum Zitat Govaert JA, van Dijk WA, Fiocco M, Scheffer AC, Gietelink L, Wouters MWJM, Tollenaar RAEM (2016) Nationwide outcomes measurement in colorectal cancer surgery: improving quality and reducing costs. J Am Coll Surg 222(1):19–29CrossRefPubMed Govaert JA, van Dijk WA, Fiocco M, Scheffer AC, Gietelink L, Wouters MWJM, Tollenaar RAEM (2016) Nationwide outcomes measurement in colorectal cancer surgery: improving quality and reducing costs. J Am Coll Surg 222(1):19–29CrossRefPubMed
12.
Zurück zum Zitat Maurer CA, Dietrich D, Schilling MK, Metzger U, Laffer U, Buchmann P, Lerf B, Villiger P, Melcher G, Klaiber C, Bilat C, Brauchli P, Terracciano L, Kessler K (2017) Prospective multicenter registration study of colorectal cancer: significant variations in radicality and oncosurgical quality—Swiss Group for Clinical Cancer Research Protocol SAKK 40/00. Int J Color Dis 32(1):57–74CrossRef Maurer CA, Dietrich D, Schilling MK, Metzger U, Laffer U, Buchmann P, Lerf B, Villiger P, Melcher G, Klaiber C, Bilat C, Brauchli P, Terracciano L, Kessler K (2017) Prospective multicenter registration study of colorectal cancer: significant variations in radicality and oncosurgical quality—Swiss Group for Clinical Cancer Research Protocol SAKK 40/00. Int J Color Dis 32(1):57–74CrossRef
13.
Zurück zum Zitat Kanters A, Mullard AJ, Arambula J, Fasbinder L, Krapohl G, Wong SL, Campbell da Jr, Hendren S (2016) Colorectal cancer: quality of surgical care in Michigan. Am J Surg 213(3):548–552CrossRefPubMedPubMedCentral Kanters A, Mullard AJ, Arambula J, Fasbinder L, Krapohl G, Wong SL, Campbell da Jr, Hendren S (2016) Colorectal cancer: quality of surgical care in Michigan. Am J Surg 213(3):548–552CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Becerra AZ, Probst CP, Tejani MA, Aquina CT, González MG, Hensley BJ, Noyes K, Monson JRT, Fleming FJ (2015) Opportunity lost: adjuvant chemotherapy in patients with stage III colon cancer remains underused. Surgery 158(3):692–699CrossRefPubMed Becerra AZ, Probst CP, Tejani MA, Aquina CT, González MG, Hensley BJ, Noyes K, Monson JRT, Fleming FJ (2015) Opportunity lost: adjuvant chemotherapy in patients with stage III colon cancer remains underused. Surgery 158(3):692–699CrossRefPubMed
15.
Zurück zum Zitat Schootman M, Lian M, Pruitt SL, Hendren S, Mutch M, Deshpande AD, Jeffe DB, Davidson NO (2014) Hospital and geographic variability in two colorectal cancer surgery outcomes: complications and mortality after complications. Ann Surg Oncol 21(8):2659–2666CrossRefPubMedPubMedCentral Schootman M, Lian M, Pruitt SL, Hendren S, Mutch M, Deshpande AD, Jeffe DB, Davidson NO (2014) Hospital and geographic variability in two colorectal cancer surgery outcomes: complications and mortality after complications. Ann Surg Oncol 21(8):2659–2666CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Munro A, Brown M, Niblock P, Steele R, Carey F (2015) Do multidisciplinary team (MDT) processes influence survival in patients with colorectal cancer? A population-based experience. BMC Cancer 15:686CrossRefPubMedPubMedCentral Munro A, Brown M, Niblock P, Steele R, Carey F (2015) Do multidisciplinary team (MDT) processes influence survival in patients with colorectal cancer? A population-based experience. BMC Cancer 15:686CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Lorenzon L, La Torre M, Ziparo V et al (2014) Evidence based medicine and surgical approaches for colon cancer: evidences, benefits and limitations of the laparoscopic vs open resection. World J Gastroenterol 20(13):3680–3692CrossRefPubMedPubMedCentral Lorenzon L, La Torre M, Ziparo V et al (2014) Evidence based medicine and surgical approaches for colon cancer: evidences, benefits and limitations of the laparoscopic vs open resection. World J Gastroenterol 20(13):3680–3692CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Spanjersberg WR, van Sambeeck JD, Bremers A, Rosman C, van Laarhoven CJ (2015) Systematic review and meta-analysis for laparoscopic versus open colon surgery with or without an ERAS programme. Surg Endosc 29(12):3443–3453CrossRefPubMedPubMedCentral Spanjersberg WR, van Sambeeck JD, Bremers A, Rosman C, van Laarhoven CJ (2015) Systematic review and meta-analysis for laparoscopic versus open colon surgery with or without an ERAS programme. Surg Endosc 29(12):3443–3453CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Theophilus M, Platell C, Spilsbury K (2014) Long-term survival following laparoscopic and open colectomy for colon cancer: a meta-analysis of randomized controlled trials. Color Dis 16(3):O75–O81CrossRef Theophilus M, Platell C, Spilsbury K (2014) Long-term survival following laparoscopic and open colectomy for colon cancer: a meta-analysis of randomized controlled trials. Color Dis 16(3):O75–O81CrossRef
20.
Zurück zum Zitat Arezzo A, Passera R, Salvai A, Arolfo S, Allaix ME, Schwarzer G, Morino M (2015) Laparoscopy for rectal cancer is oncologically adequate: a systematic review and meta-analysis of the literature. Surg Endosc 29(2):334–348CrossRefPubMed Arezzo A, Passera R, Salvai A, Arolfo S, Allaix ME, Schwarzer G, Morino M (2015) Laparoscopy for rectal cancer is oncologically adequate: a systematic review and meta-analysis of the literature. Surg Endosc 29(2):334–348CrossRefPubMed
24.
Zurück zum Zitat Dobbins TA, Young JM, Solomon MJ (2014) Uptake and outcomes of laparoscopically assisted resection for colon and rectal cancer in Australia: a population-based study. Dis Colon Rectum 57(4):415–422CrossRefPubMed Dobbins TA, Young JM, Solomon MJ (2014) Uptake and outcomes of laparoscopically assisted resection for colon and rectal cancer in Australia: a population-based study. Dis Colon Rectum 57(4):415–422CrossRefPubMed
25.
Zurück zum Zitat Allaix ME, Arezzo A, Morino M (2016) Transanal endoscopic microsurgery for rectal cancer: T1 and beyond? An evidence-based review. Surg Endosc 30(11):4841–4852CrossRefPubMed Allaix ME, Arezzo A, Morino M (2016) Transanal endoscopic microsurgery for rectal cancer: T1 and beyond? An evidence-based review. Surg Endosc 30(11):4841–4852CrossRefPubMed
26.
Zurück zum Zitat Nagtegaal ID, van de Velde CJH, van der Worp E, Kapiteijn E, Quirke P, van Krieken JHJM, the Pathology Review Committee for the Cooperative Clinical Investigators of the Dutch Colorectal Cancer Group (2002) Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 20(7):1729–1734CrossRefPubMed Nagtegaal ID, van de Velde CJH, van der Worp E, Kapiteijn E, Quirke P, van Krieken JHJM, the Pathology Review Committee for the Cooperative Clinical Investigators of the Dutch Colorectal Cancer Group (2002) Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 20(7):1729–1734CrossRefPubMed
27.
Zurück zum Zitat Quirke P, Dixon MF (1988) The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Color Dis 3(2):127–131CrossRef Quirke P, Dixon MF (1988) The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Color Dis 3(2):127–131CrossRef
28.
Zurück zum Zitat West NP, Morris EJ, Rotimi O, Cairns A, Finan PJ, Quirke P (2008) Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol 9(9):857–865CrossRefPubMed West NP, Morris EJ, Rotimi O, Cairns A, Finan PJ, Quirke P (2008) Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol 9(9):857–865CrossRefPubMed
29.
Zurück zum Zitat Lu ZR, Rajendran N, Lynch AC, Heriot AG, Warrier SK (2016) Anastomotic leaks after restorative resections for rectal cancer compromise cancer outcomes and survival. Dis Colon Rectum 59(3):236–244CrossRefPubMed Lu ZR, Rajendran N, Lynch AC, Heriot AG, Warrier SK (2016) Anastomotic leaks after restorative resections for rectal cancer compromise cancer outcomes and survival. Dis Colon Rectum 59(3):236–244CrossRefPubMed
30.
Zurück zum Zitat McSorley ST, Horgan PG, McMillan DC (2016) The impact of the type and severity of postoperative complications on long-term outcomes following surgery for colorectal cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol 97:168–177CrossRefPubMed McSorley ST, Horgan PG, McMillan DC (2016) The impact of the type and severity of postoperative complications on long-term outcomes following surgery for colorectal cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol 97:168–177CrossRefPubMed
31.
Zurück zum Zitat Stormark K, Søreide K, Søreide JA, Kvaløy JT, Pfeffer F, Eriksen MT, Nedrebø BS, Kørner H (2016) Nationwide implementation of laparoscopic surgery for colon cancer: short-term outcomes and long-term survival in a population-based cohort. Surg Endosc 30(11):4853–4864CrossRefPubMed Stormark K, Søreide K, Søreide JA, Kvaløy JT, Pfeffer F, Eriksen MT, Nedrebø BS, Kørner H (2016) Nationwide implementation of laparoscopic surgery for colon cancer: short-term outcomes and long-term survival in a population-based cohort. Surg Endosc 30(11):4853–4864CrossRefPubMed
Metadaten
Titel
Improved perioperative care is associated with improved long-term survival in colorectal cancer
verfasst von
Eligijus Poskus
Marius Kryzauskas
Tomas Poskus
Saulius Mikalauskas
Narimantas Evaldas Samalavicius
Oleg Aliosin
Sarunas Dailidenas
Algimantas Tamelis
Zilvinas Saladzinskas
Paulius Lizdenis
Audrone Jakaitiene
Giedre Smailyte
Kestutis Strupas
Publikationsdatum
12.03.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Colorectal Disease / Ausgabe 6/2018
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-018-3021-y

Weitere Artikel der Ausgabe 6/2018

International Journal of Colorectal Disease 6/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.